ANN ARBOR, Mich.--(BUSINESS WIRE)--Jun 12, 2025-- Courage Therapeutics, a company at the forefront of developing treatments for obesity and eating disorders, today announced the appointment of Giovanni Ferrara as its Chief Executive Officer. This announcement follows a significant investment earlier in May led by Arsenal Bridge Ventures, which has positioned the company to accelerate development of its promising targeted drug candidates that could further advance the treatment landscape for these conditions. Dan Housman, founding CEO of Courage Therapeutics, will continue to actively contribute to the company's success as a board member, leveraging his deep expertise and commitment to the vision he helped establish with co-founder Dr. Roger Cone, a professor of molecular and integrative physiology at the University of Michigan.